We serve 4,6-Dimethyl-2-methylsulfonylpyrimidine CAS:35144-22-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name: 4,6-Dimethyl-2-methylsulfonylpyrimidine
CAS.NO: 35144-22-0
Synonyms:4,6-dimethyl-2-methylsulfonyl-1,3-pyrimidine
4,6-dimethyl 2-(methylsulfonyl)pyrimidine
4,6-Dimethyl-2-Methylsulfonylpyrimidine
2-methylsulphonyl-4,6-dimethyl-pyrimidine
4,6-Dimethyl-2-(methylsulfonyl)pyrimidine
Molecular Formula: C7H10N2O2S
Molecular Weight:186.23100
Physical and Chemical Properties:
Density: 1.239g/cm3
Boiling point: 358.3ºC at 760 mmHg
Melting point: 84-86°C
Flash point: 170.5ºC
Refractive index: 1.511
Specification:
Appearance: White crystalline powder
Purity: 99％
Water:0.5% Max.
Loss on drying:≤0.5%
Packing:
25kg cardboard drum or according to customer specified requirements
Storage:Store in cool place. Keep container tightly closed in a dry and well-ventilated place.
Application:Intermediates of Ambrisentan CAS:177036-94-1
Contact us for information like 4,6-Dimethyl-2-methylsulfonylpyrimidine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4,6-Dimethyl-2-(methylsulfonyl)pyrimidine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4,6-Dimethyl-2-Methylsulfonylpyrimidine Use and application,4,6-Dimethyl-2-Methylsulfonylpyrimidine technical grade,usp/ep/jp grade.
Related News: With the global industrial division of labor and the change in the business model of multinational pharmaceutical companies, the outsourced market for patented drug substances will further expand.Veratraldehyde manufacturer Here’s what Apple told CNN Business in a statement:tert-butyl (2S)-2-[5-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2 -yl)phenyl]-1H-imidazol-2-yl]pyrrolidine-1-carboxylate supplier Here’s what Apple told CNN Business in a statement:4-[(4-Chloro-2-pyrimidinyl)amino]-benzonitrile vendor “CAR T-cell therapy continues to deliver remarkable outcomes for patients with hematologic malignancies, and next-generation approaches are needed to enable broad and timely patient access and reduce the cost and complexity of therapy,” said Scott Wolchko, President and Chief Executive Officer of Fate Therapeutics.Coronaviruses (CoV) are a large family of viruses that cause illness ranging from the common cold to more severe diseases such as Middle East Respiratory Syndrome (MERS-CoV) and Severe Acute Respiratory Syndrome (SARS-CoV). A novel coronavirus (nCoV) is a new strain that has not been previously identified in humans.
